2-(3-phenyl-2-piperazinyl-3,4-dihydroquinazolin-4-yl)acetic acids as antiviral agents, especially against cytomegaloviruses

US7960387B2 · kind B2 · utility

Assignee

• Bayer Schering Pharma AG · DE

Inventors

• Tobias Wunberg · Mödling, AT
• Judith Baumeister · Wuppertal, DE
• Ulrich Betz · Reinheim, DE
• Mario Jeske · Solingen, DE
• Gerald Kleymann · Bad Salzuflen, DE
• Thomas Lampe · Mülheim an der Ruhr, DE
• Susanne Nikolic · Monheim, DE
• Jurgen Reefschlager · Oldenburg, DE
• Rudolf Schohe-Loop · Wuppertal, DE
• Frank Süβmeier · Birkenfeld, DE
• Holger Zimmermann · Falkensee, DE
• Rolf Grosser · Schwandorf, DE
• Kerstin Henninger · Wuppertal, DE
• Guy Hewlett · Wuppertal, DE
• Jörg Keldenich · Wuppertal, DE
• Thomas Kramer · Wuppertal, DE
• Peter Nell · Wuppertal, DE
• Tse-I Lin · Mechelen, BE

Key dates

• Filing date: Jan 29, 2004
• Grant date: Jun 14, 2011
• Expiry date: Apr 26, 2026

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P31/22
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to dihydroquinazolines and methods for the production thereof, the use thereof in the treatment and/or prophylaxis of diseases, in addition to the use thereof in the production of medicaments in the treatment and/or prophylaxis of diseases, especially for use as anti-viral agents, especially against cytomegalo viruses.